Payal Kohli, MD
Exploring the link between atrial fibrillation and type 1 diabetes
A recent study may be first of its kind to report association while also highlights an interesting gender difference in patients.
Dose-adjusted DOACs vs Warfarin: Overview of Efficacy
Patients who require dose adjustment when taking direct oral anticoagulants have not been well studied. This large study is a good start.
Preventing Atrial Fibrillation: A Three-legged Stool
An incremental and tripartite approach to prevention, say researchers, will begin to shift AF disease distribution and decrease morbidity over time.
Atrial Fibrillation Prevention: A Three-legged Stool
A tripartite strategy targets lifestyle change, treats CV risk factors and CV disease, and encourages more global thinking.
Stroke Prevention in the Patient with Afib and T2DM: NOACs vs VKAs
Which anticoagulant therapy has the greater absolute benefit in these complex patients?
ACC Statement on Perioperative Anticoagulation: 5 questions to ask
Answers to these 5 questions about patient and pending procedure create a pathway to decisions about perioperative anticoagulation.
Afib of Less than 48 Hours: A Look at Thromboembolic Risk
New research suggests that even a short time spent in atrial fibrillation increases thromboembolic risk nearly 5-fold.
Acute Onset Palpitations in a 31-Year-Old Man
This first episode of arrhythmia occurs after completion of a customary 4-mile run. HR: 172 beats/min. View ECG here.
Amiodarone: Top 3 Things to Know for Rate or Rhythm Control of AF
Amiodarone effectively treats a wide range of tachycardias but should always be prescribed with caution. Here are 3 key points to remember.
Brush up on Your Oral Anticoagulation: A Brief Q & A
Three questions on 3 topics that are central to optimal use of OAC for patients with atrial fibrillation.